Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Research and Development and Engineering Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Amortization of Purchased Intangible Assets (USD, thousands)

Restructuring, Acquisition, and Related Costs (USD, thousands)

Total Operating Expenses (USD, thousands)

Operating Income (USD, thousands)

Interest Income (Expense), Net (USD, thousands)

Foreign Exchange Transaction Gains (Losses), Net (USD, thousands)

Other Income (Expense), Net (USD, thousands)

Income Before Income Taxes (USD, thousands)

Income Tax Provision (USD, thousands)

Net Income (USD, thousands)

Earnings per Common Share Basic (USD)

Earnings per Common Share Diluted (USD)

Weighted Average Common Shares Outstanding Basic (thousands)

Weighted Average Common Shares Outstanding Diluted (thousands)

89e69f8817c0d2b7f18068a9e52be3e04ae3685252b4520adef6be6793f65b6c

Depreciation and Amortization (USD, thousands)

Share-Based Compensation (USD, thousands)

Deferred Income Taxes (USD, thousands)

Other Adjustments (USD, thousands)

Accounts Receivable Changes (USD, thousands)

Inventories Changes (USD, thousands)

Net Cash Provided by Operating Activities (USD, thousands)

Cash Paid for Business Acquisitions, Net of Working Capital Adjustments (USD, thousands)

Purchases of Property, Plant and Equipment (USD, thousands)

Net Cash Used in Investing Activities (USD, thousands)

Borrowings Under Revolving Credit Facilities (USD, thousands)

Repayments Under Term Loan and Revolving Credit Facilities (USD, thousands)

Payments of Withholding Taxes from Share-Based Awards (USD, thousands)

Other Financing Activities (USD, thousands)

Net Cash Provided by (Used in) Financing Activities (USD, thousands)

Effect of Exchange Rates on Cash and Cash Equivalents (USD, thousands)

Increase (Decrease) in Cash and Cash Equivalents (USD, thousands)

Cash and Cash Equivalents, Beginning of Period (USD, thousands)

Cash and Cash Equivalents, End of Period (USD, thousands)

5dda45b9c956bdd8889227829face9977128b5c2def29ea37cd43a66f139016e

Cash and cash equivalents (USD, thousands)

Accounts receivable, net of allowance (USD, thousands)

Inventories (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property, plant and equipment, net (USD, thousands)

Operating lease assets (USD, thousands)

Other assets (USD, thousands)

Intangible assets, net (USD, thousands)

Goodwill (USD, thousands)

Total assets (USD, thousands)

Current portion of long-term debt (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Long-term debt (USD, thousands)

Operating lease liabilities (USD, thousands)

Other liabilities (USD, thousands)

Total liabilities (USD, thousands)

Total stockholders' equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

f6919f794ea4aca582b2a81d4a109df25da05847c8954cd35c73e1ec50070338

265d511b76b04e90a389076ef857b3a1b35269b34e6446c203e562618b303a21

28ed35a2588d5e23e0b2eda8d221d7190bb26ed57fff9b6159386a67e2e8695e

24db10074ccc16536911f758a9e7bfab56da45cea9a7a2c197a50637d17a4f6d

United States

Germany

Rest of Europe

China

Rest of Asia-Pacific

Japan

Other

Total Revenue

6c9818f0923870f0dc9ffd2ffb2518b76612efe4a72401d73dfada2040ab6be6

Photonics

Vision

Precision Motion

Laser Products

Vision Technologies

Precision Medicine and Manufacturing

- Precision Manufacturing

- Precision Medicine

Medical Solutions

Robotics and Automation

Automation Enabling Technologies

4cc023eaa0db609305461351aec6501d417c22d6f1c554a0d611f7848bc3470c

NOVANTA (NOVT)

Financials